Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × pamiparib × Clear all

Phase

Status

Completed 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Ovarian Neoplasms 1 Neoplasms 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Carcinoma, Ovarian Epithelial 1

Interventions

Drug Therapy 16 Exercise 15 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Cisplatin 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Gemcitabine 5 Cyclophosphamide 5 atezolizumab 4 Therapeutics 4 Rivaroxaban 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04985721 2023-03-15

IMPARP-HRD

Peter MacCallum Cancer Centre, Australia

Phase 2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡